-
Add to Cart The item has been addedAb176220-100μgAdecatumumab (anti-EpCAM) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab (anti-EpCAM) is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status.Purity>95% -
Add to Cart The item has been addedAb176220-10mgAdecatumumab (anti-EpCAM) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab (anti-EpCAM) is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status.Purity>95% -
Add to Cart The item has been addedAb176220-1mgAdecatumumab (anti-EpCAM) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab (anti-EpCAM) is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status.Purity>95% -
Add to Cart The item has been addedAb176220-5mgAdecatumumab (anti-EpCAM) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab (anti-EpCAM) is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status.Purity>95% -
Add to Cart The item has been addedAb179101-100μgAlomfilimab (anti-ICOS) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS CD278), with potential immunomodulating and antineoplastic activities.Purity>95% -
Add to Cart The item has been addedAb179101-10mgAlomfilimab (anti-ICOS) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS CD278), with potential immunomodulating and antineoplastic activities.Purity>95% -
Add to Cart The item has been addedAb179101-1mgAlomfilimab (anti-ICOS) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS CD278), with potential immunomodulating and antineoplastic activities.Purity>95% -
Add to Cart The item has been addedAb179101-5mgAlomfilimab (anti-ICOS) is a human immunoglobulin G1 (IgG1) kappa monoclonal antibody that recognizes inducible T-cell co-stimulator (ICOS CD278), with potential immunomodulating and antineoplastic activities.Purity>95% -
Add to Cart The item has been addedAb179373-100μgAnrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
Add to Cart The item has been addedAb179373-10mgAnrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
Add to Cart The item has been addedAb179373-1mgAnrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as -
Add to Cart The item has been addedAb179373-5mgAnrukinzumab (anti-IL-13) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab (anti-IL-13) effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab (anti-IL-13) can be used in studies of ulcerative colitis (UC) as
